When "Best in Breed" Meets the Best in Weed

A Special Report from our Associates at Money Morning:

When it comes to ETFs in the marijuana space, all you need to do is look at ETFMG Alternative Harvest ETF (NYSEArca: MJ), the go to ETF for pot stocks.

This table gives you the market cap (or net assets for MJ), the closing price on 9/27, the stock's high and low for the year, and the historical volatility - a statistical measure of a stock's annualized price fluctuation. For reference, Tesla's historical volatility is around 65%. Also note that none of these companies are U.S.-based.

Canada-based Canopy Growth Corp. (NASDAQ: CRON) was founded in 2014 to serve the medical marijuana market in Canada. Despite its high volatility relative to the broader market, the recent price action has been relatively tame after it more than doubled in just three weeks starting in mid-August.

In fact, the stock traded flat in September, staying close to its rising 20-day moving average. Option liquidity is very good and bid/ask spreads are tight. Short interest is low, so don't look for any short covering.


The End of a Prohibition
Learn How Average Americans are Becoming Marijuana Millionaires!
Get the Full Report Here!


Founded in 2013 in Toronto, Cronos invests in companies that serve the Canadian medical marijuana market, which will expand through legalization on Oct. 17.

CRON shares nearly tripled in value in about a month, which caused its volatility to spike above 190%. But it has since calmed down as it hangs around its 20-day moving average. Short interest is negligible, and option liquidity is solid for a low-priced stock.

Next up is GW Pharmaceuticals Plc. ADR (NASDAQ: GWPH), the only one of the group from across the pond, based in the United Kingdom. Founded in 1998, GW has developed, and continues to develop, groundbreaking new prescription medicines derived from cannabis, designed to treat diseases like epilepsy and schizophrenia.

Volatility - sweet, sweet volatility - has been elevated of late due to a 30% pop in the past two weeks that culminated in an all-time high on Thursday.

As a buy-and-hold stock, it's a buy.

From a trader's perspective, what I really like about GW is that it has a foot in both the marijuana and biotech markets. That gives it a more diversified "look" that should keep downside volatility in check.

On top of that, short interest on GW has been increasing since January, pushing the short-interest ratio to right around the 10 mark.

Of course, I love stocks making new highs and garnering target increases that have high short interest, since the shorts will have to cover their bets at some point by buying the stock.

Finally, we have the speculator's dream, Tillray Inc. (NASDAQ: TLRY).

If you like gut-wrenching moves, this one's for you. Based on Vancouver Island in British Columbia, the company is a straightforward medical marijuana provider to something like 14 countries.

This company can't stay out of the news right now - for all great reasons - and it's driving some unbelievable moves.

Despite debuting in July, the stock has made an impression. Last week, for example, the stock doubled in one day and resulted in trading being halted five times in less than an hour.

Option volume on TLRY is heavy and bid/ask spreads are nice and tight.

So how do you trade these stocks? If you want a wild ride, climb aboard Tillray - just make sure you don't bet the farm (or the kids' college fund) on it. It's a choice stock for parking some speculative capital in, though.

A more traditional "buy, hold, and juice your gains" play? That's GW to a "T." With a unique line of pharmaceutical therapies (and excellent prospects for a short squeeze), the stock has a bullish future.

Note that GWPH options are not as liquid as those of the other stocks, and bid/ask spreads tend to be wider. Nevertheless, look at the near-the-money GWPH May 17, 2019 $180 call (GWPH190517C00180000) to leverage the expected upside. I like the longer expirations because option prices tend to be cheaper.

Finally, the safest play - on a budget, no less - would be a covered call on Cronos Group Inc. (NASDAQ: CRON). You can buy 100 shares for around $1,100 and sell the CRON Nov. 16, 2018 $12 call (CRON181116C00012000) for around $1.50, meaning your net cost is $950.

If Cronus goes to $12 before expiration and your shares are called away, you make a cool 25%. And if the stock drops, the call will expire worthless and you can sell another one to lower your cost basis.

Bonus Report: Turn a Small Stake into a Fortune: A new earth-shattering government announcement could completely change the legalization of marijuana - forever. In fact, thanks to this historic legislation, tiny pot stocks trading for under $5 are getting set to double, triple, or quadruple. In an exclusive interview with Money Morning, pot stock expert Michael Robinson shares all the good news - including details on five tiny weed stocks that could potentially turn a small stake into $100,000. Click here to continue.

 

Subscribe Now!

Before you go, grab your 100% free copy of our latest eBook, How to Ride Legal Weed's Historic Rise + get a free bonus trading strategy, too!

By registering you are agreeing to our Privacy Policy and Money Morning Privacy Policy